CryoBuilt takes minority stake in Chillybox and secures global rights, marking a strategic push into the at-home cryotherapy market
CryoBuilt is expanding cold therapy from commercial use to everyday routines.
The U.S. cryotherapy system maker has taken an equity stake in Chillybox, a residential cold therapy company, and secured exclusive U.S. distribution rights and full global distribution capabilities for its cryo chambers.
As part of the deal, CryoBuilt CEO Marcus Wilson has joined the Chillybox board of directors. Financial terms were not disclosed.
“CryoBuilt has built its reputation around clinical-grade, performance-focused cryotherapy,” Wilson said. “By partnering with Chillybox and joining its board, we’re not only investing in a category-defining product—we’re shaping the future of how recovery and wellness are accessed at home. This aligns perfectly with where the market is going: more personal, more convenient and more sustainable solutions for longevity.”
Best known for its commercial-grade cryotherapy chambers, the California-based CryoBuilt is now expanding into the consumer market. Chillybox’s compact, plug-and-play unit, built for home and light commercial use, delivers a dry cryotherapy experience, runs on a standard 110V outlet and starts at $25,500. The unit requires no ongoing maintenance and reaches an effective temperature of -165°F. It also includes built-in scheduling and 24/7 remote monitoring when connected to WiFi.
“This partnership is a major inflection point for Chillybox,” Chillybox co-founder and former Restore Hyper Wellness & Cryotherapy chief operating officer Stacy Donnelly said. “We designed Chillybox to be a reliable cold therapy solution you can integrate into your routine every day. CryoBuilt’s investment and distribution infrastructure instantly elevates our ability to scale and deliver on our mission.”
The addition rounds out CryoBuilt’s lineup, which now spans residential, commercial, hospitality and fitness markets, alongside its existing Everest and Polaris models.
